Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside

J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 2):S246-9.

Authors

M R Mehra¹, H O Ventura, F W Smart, D D Stapleton

Affiliation

¹ Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, La 70121, USA.

PMID: 8719495

No abstract available

Publication types

Review

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / adverse effects
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Animals
Calcium Channel Blockers / adverse effects
Calcium Channel Blockers / therapeutic use*
Coronary Artery Disease / drug therapy*
Coronary Artery Disease / pathology
Coronary Vessels / drug effects
Coronary Vessels / pathology
Heart Transplantation / pathology*
Humans
Postoperative Complications / drug therapy*
Postoperative Complications / pathology
Treatment Outcome
Tunica Intima / drug effects
Tunica Intima / pathology

Substances

Angiotensin-Converting Enzyme Inhibitors
Calcium Channel Blockers